DVAX · As filed with the SEC

Dynavax Technologies cash flow statement, by quarter

The statement as Dynavax Technologies presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Condensed Consolidated Statements of Cash Flows · USD thousands

USD thousands	Q3 2025^† 3 months ended Sep 30, 2025	Q2 2025^† 3 months ended Jun 30, 2025	Q1 2025 3 months ended Mar 31, 2025	Q4 2024^† 3 months ended Dec 31, 2024
Operating activities
Net (loss) income	26,927^†	18,721^†	(96,099)	7,050^†
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	1,291^†	1,242^†	1,173	1,184^†
Amortization of right-of-use assets	803^†	797^†	863	—
Inventory write off	(338)^†	0^†	3,976	1,880^†
Sublease termination loss (Note 5)	0^†	0^†	0	49^†
Accretion of discounts on marketable securities	(1,199)^†	(1,698)^†	(2,137)	(2,653)^†
Stock-based compensation expense	12,390^†	12,979^†	14,455	13,004^†
Bad debt expense	0^†	0^†	10,970	—
Non-cash interest expense	(2,513)^†	1,642^†	1,691	(1,116)^†
Gain on sale of assets	—	—	—	0^†
Bad debt expense (Note 9)	—	—	—	0^†
Loss on debt extinguishment	0^†	0^†	82,095	—
Changes in operating assets and liabilities:
Accounts and other receivables, net	24^†	(16,788)^†	(9,651)	28,371^†
Inventories	2,737^†	(1,284)^†	(8,325)	(9,533)^†
Prepaid manufacturing	—	—	—	6,893^†
Prepaid expenses and other current assets	3,335^†	(77)^†	(5,518)	(467)^†
Other assets	—	—	—	(312)^†
Accounts payable	1,355^†	(1,835)^†	(4,668)	1,876^†
Lease liabilities	(999)^†	(1,051)^†	(1,101)	(1,167)^†
Accrued and other liabilities	(9,984)^†	10,783^†	(7,363)	7,065^†
Net cash provided by operating activities	33,829^†	23,431^†	(19,639)	53,011^†
Investing activities
Purchases of marketable securities	(139,862)^†	(18,096)^†	(93,697)	(33,016)^†
Proceeds from maturities and redemption of marketable securities	168,422^†	114,340^†	104,535	59,860^†
Purchases of property and equipment, net	(1,237)^†	(1,452)^†	(3,928)	(3,478)^†
Proceeds from sale of assets, net of transaction costs	—	—	—	0^†
Net cash provided by (used in) investing activities	27,323^†	94,792^†	6,910	23,366^†
Financing activities
Proceeds from issuance of Convertible Notes (Note 7)	0^†	0^†	39,708	—
Payment for debt issuance costs (Note 7)	0^†	(562)^†	(3,938)	—
Payments for debt extinguishment (Note 7)	0^†	0^†	(80,938)	—
Proceeds from unwind of capped call options (Note 7)	0^†	0^†	46,554	—
Payments for repurchase of common stock (Note 11)	(572)^†	(71,170)^†	(29,465)	(100,000)^†
Proceeds from exercise of stock options	95^†	235^†	6,503	—
Proceeds from Employee Stock Purchase Plan	664^†	0^†	835	0^†
Payments for taxes related to net share settlement of restricted and performance stock units	(248)^†	(421)^†	(11,141)	(479)^†
Net cash used in financing activities	(61)^†	(71,918)^†	(31,882)	(98,875)^†
Effect of exchange rate changes on cash and cash equivalents, and restricted cash	55^†	1,100^†	458	(960)^†
Net increase (decrease) in cash and cash equivalents, and restricted cash	61,146^†	47,405^†	(44,153)	(23,458)^†
Cash and cash equivalents, and restricted cash at beginning of period	99,406	52,001	96,154	119,612
Cash and cash equivalents, and restricted cash at end of period	160,552	99,406	52,001	96,154
Supplemental disclosure of cash flow information
Cash paid during the period for income taxes	455^†	1,737^†	413	8^†
Cash paid during the period for interest	0^†	503^†	1,518	2,819^†
Reclassification of contract asset from other current assets to other assets	—	—	—	0^†
Reclassification of CEPI accrual to CEPI accrual long-term	—	—	—	0^†
Non-cash investing and financing activities:
Purchases of property and equipment, not yet paid	405^†	(346)^†	2,046	961^†
Right-of-use assets obtained in exchange of operating lease liabilities	—	—	—	925^†

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.